Editor LSA

Penny Stock Runners - Axxess Pharma Inc(OTCMKTS:AXXE), Growlife Inc(OTCBB:PHOT), Cannabis Science Inc(OTCMKTS:CBIS), Vital Products, Inc.(OTCMKTS:VTPI)

 

Lewes, DE -- (SBWIRE) -- 09/11/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Axxess Pharma Inc(OTCMKTS:AXXE), Growlife Inc(OTCBB:PHOT), Cannabis Science Inc(OTCMKTS:CBIS), Vital Products, Inc.(OTCMKTS:VTPI).

Axxess Pharma Inc(OTCMKTS:AXXE) ended higher +6.00% and complete the day at $0.530. The total number of shares changed hands during the day was 228,226. After opening at $0.50, the stock hit as high as $0.70. However, it traded between $0.46 and $1.04 over the last twelve months.

Axxess Pharma Inc., a pharmaceutical company, engages in the marketing and distribution of various pharmaceutical products and diagnostic medical devices in Canada and internationally.

For How Long AXXE will Fight for Profitability? Read This Trend Analysis report

Growlife Inc(OTCBB:PHOT) closed yesterday at $0.0350, a +2.94% increase. Around 3.97 million shares were traded, low from an-average trading volume of 5.68 million shares. The company is now valued at around $21.70 million.

Growlife, Inc., through its subsidiaries, manufactures and markets horticulture and lifestyle products in the United States and internationally. It offers LED lights for indoor growing; wireless monitoring and control equipment to operate grow room functions; and plant growing systems and accessories, including nutrients, media, timers, controls, and automated water accessories.

For How Long PHOT Gloss will Attract Investors? Find out via this report

Cannabis Science Inc(OTCMKTS:CBIS) moved +1.46 percent higher at $0.0488 and traded between $0.05 and $0.05 after opening the day at $0.05. Its performance over the last five days remained 3.83%, which stands at 5.86% for a month. Going back further than one month, 1-year performance after recent close was -2.4%.

Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance

For How Long CBIS Gloss will Attract Investors? Find out via this report

Vital Products, Inc.(OTCMKTS:VTPI) shares fall, losing -62.67 percent to close at $0.0056. The stock is down around -88.8% this year and -98.13% for the last 12 months. Around 14.00 million shares changed hands yesterday, higher from an-average trading volume of 489,419 shares.

Vital Products, Inc. operates as a business-to-business supplier of compatible printer ribbons. It also offers remanufactured and compatible laser and inkjet cartridges. The company was incorporated in 2005 and is headquartered in Laguna Woods, California.

Will VTPI Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/